Health and Healthcare
Health and Healthcare Articles
Tilray chose perhaps the worst time that it could to raise capital, as the prior trading day was the worst one that the markets have seen since the 1987 crash.
Published:
Like all developmental drug companies, Bio-Path is betting on the success of its drug candidates. Drugs that are in trials often fail, so investors need to gamble that one or more of its treatments...
Published:
he World Health Organization now has upgraded the COVID-19 outbreak to pandemic status, as the cases outside of China have risen exponentially in the past two weeks.
Published:
The February 28 short interest data have been compared with the previous figures, and short interest in these top pharmaceutical stocks decreased.
Published:
The February 28 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
It is not a new scenario where an illness or problem starts to become a big deal in the public and there is a small-cap company that “has a solution for that” which happen to be known by very few...
Published:
More and more companies are joining the fight against the coronavirus, and 24/7 Wall St. is taking a look at some of the biggest movers on the day tied to COVID-19.
Published:
Kala Pharmaceuticals said that it had positive topline results from its late-stage clinical trial for the treatment of dry eye disease.
Published:
A global coronavirus pandemic could kill more than 15 million people worldwide in just one year and cause more than $2 trillion in lost economic growth.
Published:
Consumer sentiment on Wednesday stopped a tumble that began in mid-February. Thursday's stock market action could send the Morning Consult index lower again, however, as volatility continues to rule...
Published:
Shares of Amarin have plunged in recent months. Even more troubling, there appears to no catalyst to drive them higher.
Published:
More and more companies are joining the fight against the coronavirus. Quest Diagnostics is one of the newest to make this list.
Published:
While business leaders remain optimistic about economic prospects this year, the spread of the coronavirus is beginning to tamp down enthusiasm.
Published:
Arcturus Therapeutics stock jumped on Wednesday after the company announced that it would be joining the fight against the latest coronavirus.
Published:
Ranging from very conservative to aggressive, these Raymond James health care stock picks are good additions to long-term portfolios looking to add or increase exposure to the sector.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.